Indonesia Urges Greater Transparency in Cross-Border Copyright Royalty Governance Before 35 Countries 
SaunaKits.com Opens Its Upstate South Carolina Showroom, Bringing Hands-On Sauna Shopping to the Southeast 
Encore Construction Shares Guidance to Help Homeowners Avoid Costly Water Damage Insurance Claim Mistakes Linedata Integrates AI and Prescriptive Analytics Into Its Solutions to Inform Clients’ Decisions
PARIS & NEW YORK & TORONTO & CASABLANCA, Morocco–(BUSINESS WIRE)–Linedata (Euronext Paris: LIN) (Paris:LIN), a…
London Bullion Market Association and World Gold Council Announce the Launch of the Gold Bar Integrity Programme
LONDON–(BUSINESS WIRE)–London Bullion Market Association (LBMA) and the World Gold Council (WGC) are collaborating to…
Japanese Space Industry Startup “Synspective” Raises US $100 Million in Funding
Cumulative funding reaches over US $200 million in total TOKYO, 2022, March 29 – Synspective…
Xebec Announces MOU for CO2 Capture and Sequestration Equipment with Summit Carbon Solutions
– MOU to supply large-scale CO2 compression equipment for world’s largest carbon capture and storage…
Press Release: Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver
Sanofi continues on path to industry leadership in Immunology with Dupixent® (dupilumab) as key driver…
Novelion Announces Date of Final Distribution to Registered Shareholders
VANCOUVER, British Columbia, March 28, 2022 (GLOBE NEWSWIRE) — Novelion Therapeutics Inc. (“Novelion” or the…
Heliogen, Inc. Announces Full Year 2021 Financial and Operational Results
PASADENA, Calif.–(BUSINESS WIRE)–$HLGN #ArtificialIntelligence–Heliogen, Inc. (“Heliogen” or the “Company”) (NYSE: HLGN), a leading provider of…
CANbridge Pharmaceuticals CAN108 New Drug Application/Orphan Drug Registration (NDA/ORD) for Alagille Syndrome Accepted by the Taiwan Food and Drug Administration
BEIJING & CAMBRIDGE, Mass.–(BUSINESS WIRE)–CANbridge Pharmaceuticals Inc., (“CANbridge,” stock code 1228.HK) a leading China-based global…
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Volta Inc. (VLTA) on Behalf of Investors
LOS ANGELES–(BUSINESS WIRE)–Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm,…
Communications Systems, Inc. Announces Closing of the Merger with Pineapple Energy LLC and Changes its Name to Pineapple Holdings, Inc.
Company raises $32 million in private placement Trading under “PEGY” on the Nasdaq Capital Market…
Metropolitan General Manager Issues Statement on Governor’s Executive Order on Drought
LOS ANGELES–(BUSINESS WIRE)–Adel Hagekhalil, general manager of the Metropolitan Water District of Southern California, issues…
Ozempic® 2.0 mg approved in the US for the treatment of type 2 diabetes
Bagsværd, Denmark, 28 March 2022 – Novo Nordisk today announced that the US Food and Drug…
argenx announces closing of global offering
Regulated information March 28, 2022, 10:30 PM CETMarch 28, 2022, 4:30 PM ET Breda, the Netherlands /…
Molecular Templates, Inc. Reports Fourth Quarter 2021 Financial Results
AUSTIN, Texas, March 28, 2022 (GLOBE NEWSWIRE) — Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular Templates,” or…
First Wave BioPharma Files U.S. and PCT Patent Applications for Niclosamide in Long-Haul COVID-19
BOCA RATON, Fla., March 28, 2022 (GLOBE NEWSWIRE) — First Wave BioPharma, Inc., (NASDAQ:FWBI), (“First…
Aileron Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Highlights
Several anticipated catalysts in 2022 aim to advance Aileron’s vision to bring chemoprotection against multiple…
Enzo Biochem Appoints David Bench and Kara Cannon to New Executive Management Positions
NEW YORK, NY, March 28, 2022 (GLOBE NEWSWIRE) — Enzo Biochem, Inc. (NYSE: ENZ) (“Enzo”…
DICE Therapeutics Expands Management Team and Board of Directors
Mary Riley, J.D., appointed as general counsel Lisa Bowers, MHSA, and Mittie Doyle, M.D., FACR,…
Kinnate Biopharma Inc. Reports Full Year 2021 Financial Results and Provides Operational Updates
Initiated Phase 1 clinical trial for KIN-3248 in the first quarter of 2022 Initial monotherapy…
Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results
-Initial Data from Phase 1/2 Study of Oral Fadraciclib in Solid Tumors Expected in First…